Finance

Lists
MREO:NASDAQ
Mereo BioPharma Group plc - ADR
$0.29
-0.99%
(-0.0029) 1D
$0.30
+3.31% (+0.0096)
After hours
Closed: Aug 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MREO...
Open
$0.30
High
$0.31
Low
$0.29
Mkt. cap
46.90M
Avg. vol.
6.73M
Volume
714.70K
52-wk high
$2.37
52-wk low
$0.20
EPS
-$0.18
Beta
0.30
Shares outstanding
159.69M
No. of employees
39
Open
$0.30
High
$0.31
Low
$0.29
Mkt. cap
46.90M
Avg. vol.
6.73M
Volume
714.70K
52-wk high
$2.37
52-wk low
$0.20
EPS
-$0.18
Beta
0.30
Shares outstanding
159.69M
No. of employees
39
News stories
From web sources and news partners
About Mereo BioPharma Group plc - ADR
CEODenise Scots-Knight
Employees39
Founded2015
Headquarters-
SectorBiotechnology
Websitemereobiopharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to MREO in the past 3 months
Hold
Buy
1
Hold
1
Sell
1
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MREO in the last 3 months.
Highest
Current $0.29
$3.00 (+933.06%)
Average
$3.00 (+933.06%)
Lowest
$3.00 (+933.06%)
Analyst
Recommendation
Action
Price target
Projected
Date
Priyanka Grover
J.P. Morgan
Sell
Downgraded
-
-
08/18/2026
Kate Dellorusso
LifeSci Capital
Hold
Maintained
-
-
08/15/2026
Gil Blum
Needham
Buy
Maintained
$3.00
+933.1%
08/11/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$3.00
+933.1%
05/12/2026
Julian Harrison
BTIG
Buy
Maintained
$1.00
+244.4%
03/19/2026
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.82M
3.72M
4.65M
1.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.04M
4.20M
4.02M
5.22M
Operating expense
9.87M
7.62M
8.67M
6.91M
Total operating expenses
9.87M
7.62M
8.67M
6.91M
Operating income
-9.87M
-7.62M
-8.67M
-6.91M
Other non operating income
496.00K
-6.00K
17.00K
6.00K
EBT including unusual items
-7.02M
-7.35M
-6.72M
-7.00M
EBT excluding unusual items
-7.02M
-7.35M
-6.72M
-7.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-300.00K
-
-
Net income
-7.02M
-7.35M
-6.72M
-7.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
504.00K
421.00K
327.00K
278.00K
Interest expense
-28.00K
-23.00K
-20.00K
-16.00K
Net interest expenses
476.00K
398.00K
307.00K
262.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.82M
-7.16M
-8.50M
-6.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps